Plicit Capital Corp Stock Toronto S.E.
Equities
PLPh
CA7291431079
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- | - |
|
06-21 | Telo Genomics Corp. announced that it has received CAD 0.65 million in funding | CI |
06-18 | Telo Genomics' Myeloma Test Accepted as Lab Developed Test by College of American Pathologists | MT |
Sales 2022 | - | Sales 2023 | - | Capitalization | 20.99M 0 28.57M |
---|---|---|---|---|---|
Net income 2022 | -2M - -2.72M | Net income 2023 | -2M - -2.72M | EV / Sales 2022 | - |
Net cash position 2022 | 2.65M 0 3.61M | Net cash position 2023 | 2.64M 0 3.59M | EV / Sales 2023 | - |
P/E ratio 2022 |
-9.95
x | P/E ratio 2023 |
-6.29
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 94.66% |
Managers | Title | Age | Since |
---|---|---|---|
Kris Weinberg
CEO | Chief Executive Officer | - | 22-12-11 |
Sherif Louis
PSD | President | - | 14-12-31 |
Christopher Ross
DFI | Director of Finance/CFO | - | 21-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
William Meekison
BRD | Director/Board Member | 58 | 18-06-30 |
Director/Board Member | - | 22-02-02 | |
Guido Baechler
CHM | Chairman | 59 | 19-02-27 |
1st Jan change | Capi. | |
---|---|---|
-41.62% | 7.97B | |
+5.03% | 3.48B | |
-9.10% | 2.07B | |
-29.56% | 1.83B | |
-21.96% | 1.64B | |
+6.72% | 928M | |
-9.17% | 690M | |
-30.82% | 500M | |
-16.50% | 248M |
- Stock Market
- Equities
- TELO Stock
- PLPh Stock